Skip to main content
Erschienen in: Abdominal Radiology 1/2016

01.01.2016

Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA)

verfasst von: Sharon Ngu, Lizza Lebron-Zapata, Christy Pomeranz, Seth Katz, Scott Gerst, Junting Zheng, Chaya Moskowitz, Richard K. G. Do

Erschienen in: Abdominal Radiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to assess the inter-observer agreement on the qualitative and quantitative evaluation of relative signal intensity of liver lesions on delayed hepatobiliary phase (HBP) MRI with gadoxetate (Gd-EOB-DTPA).

Methods

105 patients with liver lesions, who had delayed HPB MRI using gadoxetate were reviewed retrospectively. For each patient, four readers (two fellows in training and two attending radiologists) qualitatively assessed the relative SI of the largest representative lesion on a five point scale, and quantitatively measured the relative SI of the lesion to adjacent liver parenchyma using region of interests (ROI). Intra-class correlation (ICC) and kappa statistics with quadratic weights (k) analysis, and maximally selected rank statistic were performed.

Results

Substantial agreement between fellows (k = 0.719; ICC = 0.705) and almost perfect agreement between attending radiologists (k = 0.853; ICC = 0.849) were found for both qualitative and quantitative assessments of relative SI on delayed HPB imaging. A cut-off ratio to differentiate between hypointense and iso- to hyperintense lesions by ROI was calculated to be 0.90.

Conclusion

Inter-observer agreement of liver lesion relative SI on delayed HBP imaging is high and may improve with radiologist experience. A cut-off ratio of relative SI at 0.90 may be useful to quantitatively distinguish hypointense from iso- to hyperintense liver lesions.
Literatur
1.
Zurück zum Zitat Ba-Ssalamah A, et al. (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19(2):342–357CrossRefPubMed Ba-Ssalamah A, et al. (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19(2):342–357CrossRefPubMed
2.
Zurück zum Zitat Hammerstingl R, et al. (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18(3):457–467CrossRefPubMed Hammerstingl R, et al. (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18(3):457–467CrossRefPubMed
3.
Zurück zum Zitat Huppertz A, et al. (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230(1):266–275CrossRefPubMed Huppertz A, et al. (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230(1):266–275CrossRefPubMed
5.
Zurück zum Zitat Reimer P, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177–183CrossRefPubMed Reimer P, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199(1):177–183CrossRefPubMed
6.
Zurück zum Zitat Seale MK, et al. (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29(6):1725–1748CrossRefPubMed Seale MK, et al. (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29(6):1725–1748CrossRefPubMed
7.
Zurück zum Zitat Vogl TJ, et al. (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200(1):59–67CrossRefPubMed Vogl TJ, et al. (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200(1):59–67CrossRefPubMed
8.
Zurück zum Zitat Zech CJ, et al. (2013) Consensus report of the fifth international forum for liver MRI. Am J Roentgenol 201(1):97–107CrossRef Zech CJ, et al. (2013) Consensus report of the fifth international forum for liver MRI. Am J Roentgenol 201(1):97–107CrossRef
9.
Zurück zum Zitat Bieze M, et al. (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. Am J Roentgenol 199(1):26–34CrossRef Bieze M, et al. (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. Am J Roentgenol 199(1):26–34CrossRef
10.
Zurück zum Zitat Grazioli L, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262(2):520–529CrossRefPubMed Grazioli L, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262(2):520–529CrossRefPubMed
11.
Zurück zum Zitat Mohajer K, et al. (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36(3):686–696PubMedCentralCrossRefPubMed Mohajer K, et al. (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36(3):686–696PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Morana G, et al. (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 46(4):225–239CrossRefPubMed Morana G, et al. (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 46(4):225–239CrossRefPubMed
13.
Zurück zum Zitat Purysko AS, et al. (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. Am J Roentgenol 198(1):115–123CrossRef Purysko AS, et al. (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. Am J Roentgenol 198(1):115–123CrossRef
14.
Zurück zum Zitat Charny CK, et al. (2001) Management of 155 patients with benign liver tumours. Br J Surg 88(6):808–813CrossRefPubMed Charny CK, et al. (2001) Management of 155 patients with benign liver tumours. Br J Surg 88(6):808–813CrossRefPubMed
15.
Zurück zum Zitat Narita M, et al. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44(7):793–798CrossRefPubMed Narita M, et al. (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44(7):793–798CrossRefPubMed
16.
Zurück zum Zitat Shimofusa R, et al. (2010) Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. J Hepatobiliary Pancreat Sci 17(5):583–589CrossRefPubMed Shimofusa R, et al. (2010) Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. J Hepatobiliary Pancreat Sci 17(5):583–589CrossRefPubMed
17.
Zurück zum Zitat Tsuboyama T, et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255(3):824–833CrossRefPubMed Tsuboyama T, et al. (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255(3):824–833CrossRefPubMed
18.
Zurück zum Zitat Bankier AA, et al. (2010) Consensus interpretation in imaging research: is there a better way? Radiology 257(1):14–17CrossRefPubMed Bankier AA, et al. (2010) Consensus interpretation in imaging research: is there a better way? Radiology 257(1):14–17CrossRefPubMed
19.
Zurück zum Zitat Davenport MS, et al. (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272(1):132–142PubMedCentralCrossRefPubMed Davenport MS, et al. (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272(1):132–142PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Kitao A, et al. (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265(3):780–789CrossRefPubMed Kitao A, et al. (2012) Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images. Radiology 265(3):780–789CrossRefPubMed
21.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
22.
Zurück zum Zitat Lausen B, Schumacher M (1992) Maximally selected rank statistics. Biometrics 48(1):73–85CrossRef Lausen B, Schumacher M (1992) Maximally selected rank statistics. Biometrics 48(1):73–85CrossRef
Metadaten
Titel
Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA)
verfasst von
Sharon Ngu
Lizza Lebron-Zapata
Christy Pomeranz
Seth Katz
Scott Gerst
Junting Zheng
Chaya Moskowitz
Richard K. G. Do
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0609-3

Weitere Artikel der Ausgabe 1/2016

Abdominal Radiology 1/2016 Zur Ausgabe

Classics in Abdominal Imaging

The perianal “horseshoe”

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.